(EIGR) Eiger Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eiger Biopharmaceuticals | (EIGR) share price targets
Complete technical analysis of Eiger Biopharmaceuticals (EIGR) by charts plus indicators, forecast predictions and share price targets for Eiger Biopharmaceuticals (EIGR)
Eiger Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-02-21 View latest technical analysis
10 day averaged volume of Eiger Biopharmaceuticals is 5710
Date | Daily Closing Price | Open | High | Low | Volume |
21 Wed Feb 2024 | 5.80 | 5.65 | 5.98 | 5.61 | 0.595 times |
20 Tue Feb 2024 | 5.74 | 5.73 | 5.74 | 5.60 | 0.508 times |
16 Fri Feb 2024 | 5.73 | 6.06 | 6.06 | 5.68 | 0.473 times |
15 Thu Feb 2024 | 5.68 | 5.70 | 6.07 | 5.68 | 0.49 times |
14 Wed Feb 2024 | 5.80 | 5.80 | 5.82 | 5.80 | 0.368 times |
13 Tue Feb 2024 | 5.82 | 5.81 | 5.82 | 5.70 | 1.191 times |
12 Mon Feb 2024 | 5.81 | 5.85 | 6.23 | 5.76 | 3.135 times |
09 Fri Feb 2024 | 5.76 | 6.09 | 6.14 | 5.76 | 1.559 times |
08 Thu Feb 2024 | 5.96 | 6.18 | 6.25 | 5.88 | 1.208 times |
07 Wed Feb 2024 | 6.40 | 6.39 | 6.40 | 6.22 | 0.508 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 5.7 as stoploss in an intra day buy trade for a target of 6.07. However, stock will show a bearish move below 5.7.
Share price targets for Eiger Biopharmaceuticals (EIGR)
Target Type | Value |
Downside Target | 0.20 |
Downside Target | 0.21 |
Downside Target | 0.27 |
Downside Target | 0.36 |
Downside Target | 0.37 |
Downside Target | 0.48 |
Downside Target | 5.60 |
Upside Target | 5.98 |
Upside Target | 6.23 |
Upside Target | 6.77 |
Upside Target | 7.02 |
Upside Target | 7.18 |
Upside Target | 7.92 |
Intraday share price targets for Eiger Biopharmaceuticals (EIGR)
Target Type | Value |
Downside Intraday Target | 5.61 |
Downside Intraday Target | 5.41 |
Upside Intraday Target | 5.99 |
Upside Intraday Target | 6.17 |
Downside Intraday Target | 5.79 |
Weekly technical analysis of Eiger Biopharmaceuticals (EIGR)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Wed Feb 2024 | 5.80 | 5.73 | 5.98 | 5.60 | 0.195 times |
16 Fri Feb 2024 | 5.73 | 5.85 | 6.23 | 5.68 | 1.252 times |
09 Fri Feb 2024 | 5.76 | 6.71 | 6.77 | 5.76 | 0.684 times |
02 Fri Feb 2024 | 6.51 | 5.88 | 7.18 | 5.81 | 1.428 times |
26 Fri Jan 2024 | 5.88 | 6.76 | 7.02 | 5.75 | 0.974 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Eiger Biopharmaceuticals (EIGR)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Wed Feb 2024 | 5.80 | 6.76 | 7.18 | 5.60 | 0.068 times |
31 Wed Jan 2024 | 6.89 | 0.23 | 7.92 | 0.20 | 0.145 times |
29 Fri Dec 2023 | 0.22 | 0.36 | 0.36 | 0.20 | 2.174 times |
30 Thu Nov 2023 | 0.34 | 0.27 | 0.48 | 0.27 | 0.533 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eiger Biopharmaceuticals (EIGR)
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eiger Biopharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Eiger Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.84 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eiger Biopharmaceuticals ( (EIGR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eiger Biopharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Eiger Biopharmaceuticals in short term but the sell signal is initial and weak.
Eiger Biopharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eiger Biopharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Eiger Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.84 and Eiger Biopharmaceuticals (EIGR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eiger Biopharmaceuticals (EIGR) stock. Volume based technical analysis of Eiger Biopharmaceuticals (EIGR) stock is negative.
Eiger Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.